))
Smart Biotech Scientist | Master Bioprocess CMC Development, Biologics Manufacturing & Scale-up for Busy Scientists
«
»
47: Mastering Process Economics: Driving Down Costs in Antibody Production w/ Brian Kelley - Part 1
Manage episode 414012566 series 3525243
Content provided by David Brühlmann: Biotech Entrepreneur & Cell Culture Technology Innovation Aficionado, David Brühlmann: Biotech Entrepreneur, and Cell Culture Technology Innovation Aficionado. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by David Brühlmann: Biotech Entrepreneur & Cell Culture Technology Innovation Aficionado, David Brühlmann: Biotech Entrepreneur, and Cell Culture Technology Innovation Aficionado or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Join us in this enlightening episode as we explore process economics with industry expert Brian Kelley. He is the Senior Vice President of Process Development at VIR Biotechnology.
Unraveling the mysteries of cost management in antibody therapeutics, Brian sheds light on the intricate challenges faced by biotech scientists and engineers.
Key Highlights:
- Discover the nuanced interplay between technical and cultural obstacles in process development.
- Navigate the labyrinth of cost drivers in antibody manufacturing, from raw materials to labor expenses.
- Learn the art of balancing speed, quality, and cost-effectiveness in bringing therapeutics to market.
Tune in for a masterclass in maximizing efficiency and driving down costs in the dynamic landscape of biologics production.
Connect with Brian Kelley:
LinkedIn: https://www.linkedin.com/in/brian-kelley-3389375
Next Step:
Enhance your bioprocess development strategy! Schedule your free assessment to propel your success: https://bruehlmann-consulting.com/assessment
71 episodes
Share
